Pentoxifylline for the Prevention of Postsurgical Keloid Recurrence.

Dermatol Surg

Department of Dermatology and McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas.

Published: October 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164298PMC
http://dx.doi.org/10.1097/DSS.0000000000002090DOI Listing

Publication Analysis

Top Keywords

pentoxifylline prevention
4
prevention postsurgical
4
postsurgical keloid
4
keloid recurrence
4
pentoxifylline
1
postsurgical
1
keloid
1
recurrence
1

Similar Publications

Managing strategies of chemotherapy and radiotherapy-induced oral mucositis.

Cancer Treat Rev

January 2025

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address:

Radiotherapy and chemotherapy are widely employed as primary non-surgical cancer treatments; however, their non-selective cytotoxicity often leads to adverse events such as oral mucositis (OM), particularly in head and neck cancer therapies. International guidelines provide recommendations for managing chemoradiotherapy-induced OM in various clinical contexts. Subsequently, emerging researches have introduced evidence supporting novel approaches or existing regimens for OM prevention and treatment.

View Article and Find Full Text PDF

There is limited understanding of the optimal duration and dosage of pentoxifylline (PTX) therapy required to achieve significant reductions in atherosclerotic cardiovascular disease (ASCVD) risk, particularly in patients with diabetic kidney disease (DKD). This study aimed to evaluate the impact of long-term PTX therapy on the risk of ASCVD in patients with DKD who do not have pre-existing cardiovascular disease, while also exploring potential vascular protective mechanisms. This retrospective cohort study included data from Taiwan's Ministry of Health and Welfare's Health and Welfare Data Science Center.

View Article and Find Full Text PDF

Introduction: Venous leg ulcers (VLU) are the most severe manifestation of venous insufficiency and carry a poor prognosis because of delayed healing and recurrent ulceration. Pentoxifylline (PTX) is an example of a vasoactive medication that can be used alongside compression therapy to help improve ulcer healing rates. A previous review highlighted improved healing of VLU with PTX, although no analysis was made for complete ulcer healing and recurrence following treatment.

View Article and Find Full Text PDF

Introduction And Objectives: The short-term mortality of severe alcoholic hepatitis (SAH) is high, but there are no effective treatments to improve short-term mortality other than corticosteroids. This study investigated the effects of adding rifaximin to standard treatment in patients with SAH.

Material And Methods: In this randomized controlled open-label trial, patients with SAH (Maddrey's discriminant function≥32) were randomized to the rifaximin or control group.

View Article and Find Full Text PDF
Article Synopsis
  • Frostbite is a serious risk in mountaineering, especially in cold climates, leading to significant injuries like those seen in three climbers on Denali in 2021.
  • All affected climbers, healthy men in their 30s to 60s, suffered frostbite primarily on their fingers, with one requiring medical evacuation due to severity.
  • Key prevention strategies and awareness of frostbite risks are crucial for mountaineers, especially considering factors like altitude, cold exposure, and potential psychological effects from the COVID-19 pandemic.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!